At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 65 enrolled / 65 target
Drug / intervention
Sufentanil Infusion +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Sufentanil Infusion vs Sufentanil Bolus and Time to Extubation During Routine Cardiac Surgery
In Brief
A Phase 4 clinical trial evaluating Sufentanil Infusion and Sufentanil Bolus for Anesthesia. Completed, enrolled 65 participants across 1 site.
Detailed Summary
Randomized single blind controlled clinical trial to test the benefit of sufentanil infusion over bolus dosing to reduce time to extubation and reduced length of ICU stay.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnesthesia
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2020202120222023202420252026
First PostedJan 2020
Enrollment StartOct 2020
Primary CompletionOct 2021
TodayJul 2026
First PostedJan 13, 2020
Enrollment StartOct 13, 2020
Primary CompletionOct 28, 2021
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 6.5 years ago
Arms & Interventions
Sufentanil Bolusactive_comparator
medication in scheduled doses (bolus)
Drug: Sufentanil Bolus
Sufentanil Infusionexperimental
medication in a slow trickle (infusion)
Drug: Sufentanil Infusion
Interventions
Sufentanil Infusiondrug
Intra-operative sufentanil infusion
Sufentanil Bolusdrug
Intra-operative sufentanil bolus